MMED logo

MiniMed Group Inc. (MMED)

$17.78

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on MMED

Market cap

$5.00B

EPS

-0.47

P/E ratio

--

Price to sales

2.45

Dividend yield

--

Beta

-2.218661

Price on MMED

Previous close

$18.65

Today's open

$18.59

Day's range

$17.74 - $18.61

52 week range

$10.65 - $24.43

Profile about MMED

CEO

--

Employees

8000

Headquarters

Northridge, CA

Exchange

Nasdaq Global Select

Shares outstanding

281349931

Issue type

Common Stock

MMED industries and sectors

Healthcare

Medical Equipment & Supplies

News on MMED

MiniMed Launches MiniMed Flex Pump in Europe to Expand Diabetes Care

MMED launches compact Flex insulin pump in Europe, combining app-based control and SmartGuard technology to expand diabetes care portfolio and reach.

news source

Zacks Investment Research • 4 hours ago

news preview

MiniMed: The Split-Off Hangover Is Hiding A Full-Stack Product Cycle

I see MiniMed Group shifting from share donor to share taker as split-off selling obscures its product-cycle progress. MMED's Q1 organic growth accelerated to 15.8%; new U.S. pump volumes rose over 20%, supporting a business with roughly 80% recurring revenue. Flex, the Fit patch pump, and Vivera could complete MMED's portfolio by late 2027, though regulatory, competitive, and separation risks remain.

news source

Seeking Alpha • 13 hours ago

news preview

MiniMed Launches MiniMed Flex™, its Smallest and Most Discrete Insulin Pump, in Europe

New app-controlled pump aims to make diabetes management easier and combines dependable clinical performance with convenient design NORTHRIDGE, Calif., Nov. 17, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED) a global leader in diabetes technology, today began commercial shipments of the MiniMed Flex™ system across Europe, following an initial customer experience phase in select markets.

news source

PRNewsWire • Nov 17, 2026

news preview

FDA Clears MiniMed Fit Tubeless Insulin Pump with Seven-Day Wear

MiniMed (NASDAQ:MMED) on Monday secured U.S. Food and Drug Administration clearance for MiniMed Fit, marking the company's debut in the tubeless insulin pump market with a device offering up to seven days of wear and a 300-unit insulin capacity.

news source

Benzinga • Nov 16, 2026

news preview

FDA Clears MiniMed Fit™ -- World's First and Only Tubeless Insulin Pump with Up to Seven-Day Wear and Zero Interruptions

The only tubeless pump with no charging or cartridge changes for up to seven days, combined with a 300-unit insulin capacity and advanced insulin automation NORTHRIDGE, Calif., Nov. 16, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED) today announced U.S. Food and Drug Administration (FDA) clearance of MiniMed Fit™, the company's first tubeless insulin pump, offering people with diabetes a new differentiated option that combines up to seven days of wear, a 300-unit insulin capacity, app control and proven SmartGuard™ technology.

news source

PRNewsWire • Nov 16, 2026

news preview

Short Interest Powder Kegs: 10 Stocks Bears Cannot Quit Buying

Bears are crowding into a small group of stocks, and one name has nearly its entire float sold short.

news source

Benzinga • Nov 11, 2026

news preview

MiniMed to Participate in Upcoming Investor Conferences

NORTHRIDGE, Calif., Nov. 5, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced that Chad Spooner, EVP, Chief Financial Officer, will discuss and answer questions on the company at the following investor conferences: 9th Annual Evercore Healthcare Conference  Tuesday, December 1, 2026, at 10:50 a.m.

news source

PRNewsWire • Nov 5, 2026

news preview

MiniMed to Announce Its Fiscal Year 2027 Second Quarter Financial Results

NORTHRIDGE, Calif., Nov. 4, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced that it expects to report financial results on Tuesday, November 24, 2026, for its second quarter of fiscal year 2027, which ended on Friday, October 30, 2026.

news source

PRNewsWire • Nov 4, 2026

news preview

MiniMed Appoints Dr. David Segal as Chief Medical Officer

NORTHRIDGE, Calif., Nov. 3, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced the appointment of David Segal, M.D.

news source

PRNewsWire • Nov 3, 2026

news preview

MiniMed Announces Board of Directors for its Next Chapter as an Independent Company

Directors bring expertise across healthcare access, medtech, commercial and manufacturing operations and public-company governance as MiniMed begins its next chapter as an independent company focused on making every day a better day for people with diabetes. NORTHRIDGE, Calif.

news source

PRNewsWire • Oct 15, 2026

news preview

¹ Disclosures

Get started with M1

Invest in MiniMed Group Inc.

Open an M1 investment account to buy and sell MiniMed Group Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in MMED on M1